美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Renaissance International IPO ETF

21.97

-0.2309-1.04%

盤後：22.270.2961+1.35%16:10 EDT

成交量：4,466

成交額：9.86萬

市值：1,098.70萬

市盈率：- -

高：22.27

開：22.10

低：21.97

收：22.20

52周最高：26.25

52周最低：15.65

股本：50.00萬

流通股本：50.00萬

量比：2.53

換手率：0.89%

股息：0.14

股息率：0.66%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

市場消息：鎧俠正考慮在美國上市籌集100億美元。

恒瑞醫藥(01276.HK)：SHR-2004注射液的藥品上市許可申請獲國家藥監局受理

燧原科技上市首日大漲國產算力「四小龍」迎盈利大考

摩爾線程跌3.31% 二季度末永贏基金為最大流通股東

發布會提及213次，五大上市險企AI應用從「百億投入」邁向「算賬」階段？|半年報關鍵詞AI

元道通信4年造假被罰2.39億，還有3億涉訴債務誰來兜底？

恒瑞創新藥凝血因子XI單抗SHR-2004注射液用於擇期膝關節置換手術後成年患者靜脈血栓預防的上市申請獲受理

非息收入僅增0.23%，9家上市股份行忙了個「寂寞」？代理業務冰火兩重天，財富回暖為何沒能帶動中收？

恒瑞醫藥：SHR-2004注射液上市許可申請獲受理

每日经济新闻

恒瑞醫藥：SHR-2004注射液上市許可申請獲受理

海柔創新再度向港交所主板遞表聯席保薦為高盛與中信證券

观点地产网

華海藥業：阿哌沙班片獲得德國上市許可

豐收開新局實幹促振興 | 海門無花果上市銷售

【美股盤前】AI發展放緩呼聲引發市場擔憂，芯片與存儲股集體下跌，英偉達下跌2.5%，英特爾、AMD跌超5%；高管稱波士頓動力IPO條件尚不成熟；沙特管道遇襲停運，布油升逾3%

每日经济新闻

上周無新增IPO受理企業

眾鑫股份：93.07萬股戰略配售限售股將上市流通

AI 計算網絡製造商 Ligent Technologies 計劃在香港進行 IPO，合計募資最高達 57 億港元

正裕工業：3568.60萬股定增限售股9月21日上市流通

據報OpenAI明確今年不會推進上市

波士頓動力2027年IPO料難成行人形機器人商業化前路漫漫

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IPOS/news?page=12"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IPOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","market":"US","secType":"STK","nameCN":"Renaissance International IPO ETF","latestPrice":21.9739,"timestamp":1789588800000,"preClose":22.2048,"halted":0,"volume":4466,"hourTrading":{"tag":"盘后","latestPrice":22.27,"preClose":21.9739,"latestTime":"16:10 EDT","volume":6,"amount":131.8434,"timestamp":1789589404236,"change":0.2961,"changeRate":0.013475,"amplitude":0},"delay":0,"changeRate":-0.010398652543594103,"floatShares":500001,"shares":500001,"eps":0,"marketStatus":"未開盤","change":-0.2309,"latestTime":"09-16 16:00:00 EDT","open":22.1,"high":22.27,"low":21.97,"amount":98576,"amplitude":0.013511,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":22.2048,"sharesOutstanding":400001,"nav":22.2869,"aum":11143472.21,"dividendRate":0.006553,"bidAskSpread":0.005267,"postHourTrading":{"tag":"盘后","latestPrice":22.27,"preClose":21.9739,"latestTime":"16:10 EDT","volume":6,"amount":131.8434,"timestamp":1789589404236,"change":0.2961,"changeRate":0.013475,"amplitude":0},"volumeRatio":2.530312,"impliedVol":0.8998,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","floatShares":500001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.530312,"shares":500001,"dividePrice":0.144,"high":22.27,"amplitude":0.013511,"preClose":22.2048,"low":21.97,"week52Low":15.65,"pbRate":"--","week52High":26.25,"institutionHeld":0,"latestPrice":21.9739,"eps":0,"divideRate":0.006553,"volume":4466,"delay":0,"ttmEps":0,"open":22.1,"prevYearClose":16.8936,"prevWeekClose":22.665,"prevMonthClose":23.3188,"prevQuarterClose":25.635,"fiveDayClose":23.2152,"twentyDayClose":23.3147,"sixtyDayClose":26.1608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPOS\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"IPOS","amount":0.072205,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-18"},{"date":"2026-06-12","symbol":"IPOS","amount":0.054103,"announcedDate":"2026-06-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-12","defaultRemindTime":1781271000000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-12","currency":"USD","dateTimestamp":1781236800000,"payDate":"2026-06-22"},{"date":"2025-12-12","symbol":"IPOS","amount":0.017941,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-19"},{"date":"2025-09-12","symbol":"IPOS","amount":0.007352,"announcedDate":"2025-09-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-12","defaultRemindTime":1757683800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-12","currency":"USD","dateTimestamp":1757649600000,"payDate":"2025-09-19"},{"date":"2025-06-13","symbol":"IPOS","amount":0.13555,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPOS\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.10823,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.15245,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-22","value":0.05857,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-23","value":0.00775,"currency":"USD"},{"executeDate":"2018-06-15","recordDate":"2018-06-18","paymentDate":"2018-06-22","value":0.2024,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPOS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPOS\",pageSize:20,pageCount:12,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667650657","title":"市場消息：鎧俠正考慮在美國上市籌集100億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650657","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:46","pubTimestamp":1789382815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657078","title":"恒瑞醫藥(01276.HK)：SHR-2004注射液的藥品上市許可申請獲國家藥監局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:36","pubTimestamp":1789382173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765668","title":"燧原科技上市首日大漲 國產算力「四小龍」迎盈利大考","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765668","media":"经济导报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765668?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:17","pubTimestamp":1789381020,"startTime":"0","endTime":"0","summary":"随着这声锣响,摩尔线程、沐曦股份、壁仞科技、燧原科技4家国产算力芯片企业齐聚资本市场。从2025年12月摩尔线程率先上市算起,这场“会师”历时9个月。不过,燧原科技的首日表现并不算最亮眼。首日涨幅的逐级回落,本身就是一条清晰的信号——国产算力芯片在二级市场的“稀缺性溢价”,正在被稀释。截至目前,“四小龙”尚未盈利,如何撑起国产算力的市值?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuw4054012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657661","title":"摩爾線程跌3.31% 二季度末永贏基金為最大流通股東","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657661","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657661?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:08","pubTimestamp":1789380493,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 摩尔线程 今日收报346.02元，跌幅3.31%。　　截至2026年6月30日，上海浦东发展银行股份有限公司－永赢数字经济智选混合型发起式证券投资基金持有1250276股，占流通股比例为4.136%，为摩尔线程第一大流通股股东。　　摩尔线程于2026年8月10日披露了关于筹划发行H股股票并在香港联合交易所有限公司主板上市的提示性公告。本次发行并上市能否通过审议、备案和审核程序并最终实施具有重大不确定性。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914870190.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914870190.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688795","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667577326","title":"發布會提及213次，五大上市險企AI應用從「百億投入」邁向「算賬」階段？|半年報關鍵詞AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2667577326","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667577326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:08","pubTimestamp":1789380480,"startTime":"0","endTime":"0","summary":"2026年中期业绩发布会，“AI”“token”等人工智能用词，成为A股五大上市险企第一热词。213次热词的支撑，来自“十五五”开局之年的战略落子。不过，只有中国平安在报告中披露了Token消耗量，在五大上市险企中仅此一家。投入阶段已过半，进入“算账”阶段。业绩发布会上，中国人寿总裁助理、首席网络安全官张新宇表示，基于大模型的意外险、重疾险责任辅助判定投入使用，理赔时效缩短至0.36天；面向销售人员的“AI私教”培训体系已经上线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/2026-09-14/doc-iniruxus9363834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","QTOC","BK4588","BK4585","AIQ","AGIX","ARTY","VTHR","AIPO","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667465790","title":"元道通信4年造假被罰2.39億，還有3億涉訴債務誰來兜底？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667465790","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667465790?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:05","pubTimestamp":1789380300,"startTime":"0","endTime":"0","summary":"如今，因涉欺诈发行及信息披露违法行为，元道通信被罚款2.39亿元，同时退市进入倒计时。退市主要问题归于其4年的财务造假。2025年7月11日，元道通信被证监会立案调查，2026年5月8日公司收到《行政处罚事先告知书》。潘建忠、乔军文被认定为不适当人选，12个月内不得担任保荐相关职务。元道通信上市三年、案发时市值仍有二十多亿元，一旦索赔诉讼成势，收了8418万元的国新证券，面对的可能是数倍于此的赔付责任。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-14/doc-iniruxuy4522694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1960683339.HKD","LU0456827905.SGD","HK0000352291.HKD","LU0228367735.SGD","IE00BYV24P56.USD","LU0561508036.HKD","LU1226287529.USD","LU1251922891.USD","03143","IE00BVYPNQ40.USD","IE0031814852.USD","LU0880133367.SGD","LU0314109678.HKD","LU1807302812.USD","IE0008369823.USD","IE00B29SXG58.USD","LU1008478684.HKD","LU2476274308.USD","LU0244354667.USD","LU0417516902.SGD","LU0307460666.USD","LU0348805143.USD","LU1366334578.USD","LU0868486357.SGD","LU1366334651.USD","LU0588546209.SGD","IPOS","LU0431992006.USD","LU1152091754.HKD","LU1813983027.USD","LU0348814723.USD","LU0370786039.SGD","LU1242518857.USD","LU0315179316.USD","LU1282649141.HKD","LU0117841782.USD","LU2294711473.HKD","LU1328277881.USD","LU0348788117.USD","IE00BVYPNP33.GBP","LU0516422366.SGD","LU1993786604.SGD","LU1188198961.HKD","IE00BZ08YT58.USD","LU0502904849.HKD","LU0979878070.USD","LU0327786744.USD","LU1719994722.HKD","LU1831875114.USD","03968"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657738","title":"恒瑞創新藥凝血因子XI單抗SHR-2004注射液用於擇期膝關節置換手術後成年患者靜脈血栓預防的上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657738","media":"恒瑞医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657738?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:59","pubTimestamp":1789379940,"startTime":"0","endTime":"0","summary":"近日，恒瑞医药子公司北京盛迪医药有限公司收到国家药监局下发的《受理通知书》，公司1类创新药、凝血因子XI单克隆抗体SHR-2004注射液的药品上市许可申请获受理，拟定适应症为：用于择期膝关节置换手术的成年患者，以预防静脉血栓形成。该研究旨在评价行择期TKA的患者使用SHR-2004注射液预防静脉血栓栓塞症的有效性和安全性。此外，SHR-2004用于卵巢癌术后VTE预防的Ⅱ期试验已完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuy4531842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","IPOS","LNGR","MEDX","06978","159992","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965773","title":"非息收入僅增0.23%，9家上市股份行忙了個「寂寞」？代理業務冰火兩重天，財富回暖為何沒能帶動中收？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965773","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965773?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:54","pubTimestamp":1789379640,"startTime":"0","endTime":"0","summary":"部分银行的财富管理相关收入恢复较快，譬如民生银行，该行上半年代理业务手续费增长64.92%；另外，招行代理基金手续费增长61.40%，平安银行代理及委托手续费增长27.6%。今年上半年，9家股份行中，6家非息收入正增长，3家负增长。因此，非息收入增长或下降，并不能简单等同于中收的同步变化。代理业务表现“冰火两重天”进一步拆分手续费收入，财富管理业务的变化更为明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/bank/gsdt/2026-09-14/doc-iniruxuu7251063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667265224","title":"恒瑞醫藥：SHR-2004注射液上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667265224","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667265224?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:49","pubTimestamp":1789379352,"startTime":"0","endTime":"0","summary":"9月14日，恒瑞医药公告称，公司子公司北京盛迪医药收到国家药监局下发的《受理通知书》，公司1类创新药、凝血因子XI单克隆抗体SHR-2004注射液的药品上市许可申请获受理。该药品拟定适应症为用于择期膝关节置换手术的成年患者，以预防静脉血栓形成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873526173.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873526173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0012","LU2148510915.USD","LU1064131003.USD","LU2097828805.USD","BK0188","LU1997244956.HKD","LU2580892789.USD","LU0359202008.SGD","01276","BK0028","BK1191","LU1655091616.SGD","LU0359201612.USD","LU1328615791.USD","LU2328871848.SGD","LU2488822045.USD","LU2097828631.EUR","BK0060","LU2495084118.USD","BK0239","LU0405327148.USD","LU2097828474.EUR","IPOS","LU0405327494.USD","LU0359201885.HKD","LU2543165471.USD","LU1580142542.USD","LU2580892862.HKD","LU1997245094.SGD","LU1023057109.AUD","LU1820825898.SGD","LU1064130708.USD","LU1781817850.SGD","LU1969619763.USD","BK0183","LU2097828714.EUR","LU1255011170.USD","LU1997245177.USD","600276","LU2097828557.USD","BK0196","LU2289578879.USD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652502","title":"恒瑞醫藥：SHR-2004注射液上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652502?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:46","pubTimestamp":1789379185,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650823","title":"海柔創新再度向港交所主板遞表 聯席保薦為高盛與中信證券","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650823","media":"观点地产网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650823?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:43","pubTimestamp":1789378980,"startTime":"0","endTime":"0","summary":"观点网讯：9月13日，深圳市海柔创新智慧科技集团股份有限公司向港交所主板递交上市申请，联席保荐人为高盛、中信证券。招股书显示，海柔创新是一家仓储自动化领域的企业，专注于拣选自动化解决方案，拣选是仓库中最为劳动密集及耗时的活动。此次为该公司再度递表。海柔创新曾于今年2月13日向港交所递交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/estate/integration/2026-09-14/doc-iniruxuw3993623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2148510915.USD","600030","IE00B19Z3B42.SGD","BK0028","LU1781817850.SGD","LU1328615791.USD","BK4127","LU0942090050.USD","LU2237438978.USD","LU2471134796.USD","IE0004091025.USD","LU1894683264.USD","LU1146622755.USD","GSX","LU0345770993.USD","LU1668664300.SGD","LU1255011170.USD","LU1868836591.USD","LU1064131003.USD","LU0868494708.USD","LU1655091616.SGD","LU2237443978.SGD","LU2471134879.HKD","LU1720050803.USD","IPOS","LU1868836914.USD","BK4550","LU1997245177.USD","BK1516","LU0048573561.USD","BK4585","LU0106831901.USD","LU2237443382.USD","IE0002270589.USD","BK1521","BK1147","BK0012","BK4552","06030","LU0345770308.USD","BK0183","LU0742534661.SGD","LU1580142542.USD","HEXmain","LU2237443465.HKD","IE00B19Z3581.USD","LU0251142724.SGD","LU1997244956.HKD","LU2237443549.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654723","title":"華海藥業：阿哌沙班片獲得德國上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654723?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:39","pubTimestamp":1789378774,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765221","title":"豐收開新局 實幹促振興 | 海門無花果上市銷售","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765221","media":"江川发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765221?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:36","pubTimestamp":1789378560,"startTime":"0","endTime":"0","summary":"在成熟上市周期方面，基地无花果每年8月底开始陆续成熟，进入初采阶段，可供少量采摘与销售；每年9月15日后果实进入集中成熟期，大批量鲜果可上市供应，能够精准对接秋季鲜果市场需求，抢占市场销售窗口期。产量方面，基地无花果产量呈逐年稳步递增的丰产态势，种植收益稳定可期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-14/doc-iniruxus9352664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667523116","title":"【美股盤前】AI發展放緩呼聲引發市場擔憂，芯片與存儲股集體下跌，英偉達下跌2.5%，英特爾、AMD跌超5%；高管稱波士頓動力IPO條件尚不成熟；沙特管道遇襲停運，布油升逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667523116","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667523116?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:32","pubTimestamp":1789378366,"startTime":"0","endTime":"0","summary":"①【三大期指齐跌】截至发稿，道指期货跌0.18%，标普500指数期货跌0.69%，纳指期货跌1.72%。②【AI发展放缓呼声引发市场担忧，芯片与存储股集体下跌】9月12日，AnthropicCEO达里奥·阿莫代伊（DarioAmodei）发表文章，呼吁业界放缓AI模型的开发节奏，引发投资者广泛关注。阿莫代伊在文章中提出了一项“放缓前沿竞争”的计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873505440.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873505440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FDTX","USD","XSD","NVIW.SI","SOXL","VTHR","USO","TEKX","AGOX","ESLG","AIPO","REDS","KCE","CLSE","SSG","TTEQ","QTOC","AMD","SOXQ","PSI","CHPS","GFS","IPOS","LINT","LEGR","CNAV","CHAT","TTXU","CHPY","159813","EFIV","AIS","SOXY","CNEQ","SMHX","SOXX","SOXS","FTXL","FRHC","ARTY","INTC","DBO","SCO","NVDA","SNPE","THMR","UCO","LFGY","AGIX","SMH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693654","title":"上周無新增IPO受理企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693654?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:25","pubTimestamp":1789377948,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["REDS","BK4127","FRHC","IPOS","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654698","title":"眾鑫股份：93.07萬股戰略配售限售股將上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654698","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654698?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:25","pubTimestamp":1789377937,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654275","title":"AI 計算網絡製造商 Ligent Technologies 計劃在香港進行 IPO，合計募資最高達 57 億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654275","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654275?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:23","pubTimestamp":1789377827,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据彭博社报道，AI 计算网络制造商 Ligent Technologies Inc. 计划在香港进行 IPO，拟发行 1.72 亿股股票，发行价每股 32.96 港元，合计募资最高达 57 亿港元（约 7.27 亿美元）。该公司总部位于美国加州圣何塞，为中资背景企业。股票预计于 9 月 22 日正式挂牌交易。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2289637","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","BK4127","FRHC","QTOC","REDS","VTHR","AGIX","IPOS","AIPO","CHAT","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667565482","title":"正裕工業：3568.60萬股定增限售股9月21日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2667565482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667565482?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:18","pubTimestamp":1789377534,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651054","title":"據報OpenAI明確今年不會推進上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651054","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667651054?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:05","pubTimestamp":1789376755,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据外媒报道，OpenAI首席执行官萨姆·阿尔特曼在周末接受采访时明确指出，ChatGPT的母公司OpenAI今年不会进行首次公开募股（IPO），并直接回应称在当前的评估阶段推进上市是“不明智的”。阿尔特曼随后在社交平台X上进一步解释，前沿人工智能的研发需要循序渐进，而非盲目冲刺或停滞不前。该表态反映了近期AI行业领袖对安全性和负责任研发的共同诉求。有分析人士认为，投资者此前对AI领军企业的资本运作寄予厚望。OpenAI延缓上市进程，加上市场对行业研发速度放缓及合规成本上升的担忧，直接打压了风险偏好。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305983","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667597216","title":"波士頓動力2027年IPO料難成行 人形機器人商業化前路漫漫","url":"https://stock-news.laohu8.com/highlight/detail?id=2667597216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667597216?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:41","pubTimestamp":1789375273,"startTime":"0","endTime":"0","summary":"现代汽车集团尚未公开披露波士顿动力潜在上市的时间表或估值目标。集团未立即回应置评请求，波士顿动力在非营业时间亦无法置评。IPO或仍需数年分析师认为，波士顿动力未来几年不太可能上市，因人形机器人仍无法在工厂广泛部署。文件显示，2021年至2025年，波士顿动力累计亏损近1.7万亿韩元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UBOT","WDRN","IQM","FRHC","RTOO","IPOS","BK4127","KCE","REDS","ROBT","PBOT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":12,"totalSize":1066,"code":"91000000","status":"200"}]}}